{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:47:00Z","timestamp":1773190020606,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11886-023-01930-6","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T07:01:58Z","timestamp":1693033318000},"page":"1103-1111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pericarditis Management in Individuals Contemplating Pregnancy, Currently Pregnant, or Breastfeeding"],"prefix":"10.1007","volume":"25","author":[{"given":"Katherine","family":"Pryor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Economy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Honigberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Garshick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"issue":"8","key":"1930_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s11886-022-01710-8","volume":"24","author":"E Lazarou","year":"2022","unstructured":"Lazarou E, Tsioufis P, Vlachopoulos C, Tsioufis C, Lazaros G. Acute pericarditis: update. Curr Cardiol Rep. 2022;24(8):905\u201313. https:\/\/doi.org\/10.1007\/s11886-022-01710-8.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"1930_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.23736\/S0031-0808.21.04198-7","volume":"63","author":"L Serati","year":"2021","unstructured":"Serati L, Carnovale C, Maestroni S, et al. Management of acute and recurrent pericarditis in pregnancy. Panminerva Med. 2021;63(3):276\u201387. https:\/\/doi.org\/10.23736\/S0031-0808.21.04198-7.","journal-title":"Panminerva Med"},{"issue":"3","key":"1930_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijcard.2009.03.028","volume":"144","author":"A Brucato","year":"2010","unstructured":"Brucato A, Imazio M, Curri S, Palmieri G, Trinchero R. Medical treatment of pericarditis during pregnancy. Int J Cardiol. 2010;144(3):413\u20134. https:\/\/doi.org\/10.1016\/j.ijcard.2009.03.028.","journal-title":"Int J Cardiol"},{"issue":"8","key":"1930_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2459\/JCM.0b013e3283352356","volume":"11","author":"M Imazio","year":"2010","unstructured":"Imazio M, Brucato A, Rampello S, et al. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11(8):557\u201362. https:\/\/doi.org\/10.2459\/JCM.0b013e3283352356.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"1930_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2217\/whe.12.9","volume":"8","author":"M Imazio","year":"2012","unstructured":"Imazio M, Brucato A. Management of pericarditis in women. Womens Health (Lond). 2012;8(3):341\u20138. https:\/\/doi.org\/10.2217\/whe.12.9.","journal-title":"Womens Health (Lond)"},{"key":"1930_CR6","doi-asserted-by":"crossref","unstructured":"Cepas Guillen PL, Martinez-Nadal G, Izquierdo M, et al. Specific sex and gender factors of pericarditis in women. Eur Heart J. 2020;41.","DOI":"10.1093\/ehjci\/ehaa946.3176"},{"issue":"14","key":"1930_CR7","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jama.2015.12763","volume":"314","author":"M Imazio","year":"2015","unstructured":"Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314(14):1498\u2013506. https:\/\/doi.org\/10.1001\/jama.2015.12763.","journal-title":"JAMA"},{"key":"1930_CR8","unstructured":"Sunitha MSC, Brid SV. Electrocardiographic Qrs Axis, Q Wave and T-wave changes in 2nd and 3rd trimester of normal pregnancy. J Clin Diagn Res. 2014;8(9):BC17-BC21."},{"issue":"7\u20138","key":"1930_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","volume":"47","author":"Z Derzsy","year":"2010","unstructured":"Derzsy Z, Prohaszka Z, Rigo J Jr, Fust G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol. 2010;47(7\u20138):1500\u20136. https:\/\/doi.org\/10.1016\/j.molimm.2010.01.021.","journal-title":"Mol Immunol"},{"issue":"11","key":"1930_CR10","first-page":"1164","volume":"108","author":"NR van den Broek","year":"2001","unstructured":"van den Broek NR, Letsky EA. Pregnancy and the erythrocyte sedimentation rate. BJOG. 2001;108(11):1164\u20137.","journal-title":"BJOG"},{"key":"1930_CR11","doi-asserted-by":"crossref","unstructured":"Stout K, Bauer A, Habib Khattak F, Biddle W. Coxsackie B virus myopericarditis in a pregnant woman with a history of benign early repolarization. J Am Coll Cardiol. 2021;77(No. 18_Supplement_1):2206.","DOI":"10.1016\/S0735-1097(21)03561-0"},{"issue":"42","key":"1930_CR12","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921\u201364. https:\/\/doi.org\/10.1093\/eurheartj\/ehv318.","journal-title":"Eur Heart J"},{"issue":"3","key":"1930_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.amjmed.2018.11.017","volume":"132","author":"J Ravichandran","year":"2019","unstructured":"Ravichandran J, Woon SY, Quek YS, et al. High-sensitivity cardiac troponin I levels in normal and hypertensive pregnancy. Am J Med. 2019;132(3):362\u20136. https:\/\/doi.org\/10.1016\/j.amjmed.2018.11.017.","journal-title":"Am J Med"},{"key":"1930_CR14","doi-asserted-by":"publisher","unstructured":"Joyal D, Leya F, Koh M, et al. Troponin I levels in patients with preeclampsia. Am J Med.\u00a02007;120(9):819 e13\u20134. https:\/\/doi.org\/10.1016\/j.amjmed.2006.05.068.","DOI":"10.1016\/j.amjmed.2006.05.068."},{"key":"1930_CR15","doi-asserted-by":"publisher","unstructured":"O'Kelly AC, Sharma G, Vaught AJ, Zakaria S. The use of echocardiography and advanced cardiac ultrasonography during pregnancy. Curr Treat Options Cardiovasc Med. 2019;21(11):71. https:\/\/doi.org\/10.1007\/s11936-019-0785-5.","DOI":"10.1007\/s11936-019-0785-5."},{"issue":"1","key":"1930_CR16","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.hlc.2020.10.001","volume":"30","author":"A Morton","year":"2021","unstructured":"Morton A. Physiological changes and cardiovascular investigations in pregnancy. Heart Lung Circ. 2021;30(1):e6\u201315. https:\/\/doi.org\/10.1016\/j.hlc.2020.10.001.","journal-title":"Heart Lung Circ"},{"key":"1930_CR17","unstructured":"Media ACoDaC. ACR Manual on contrast media. American College of Radiology; 2022. Accessed 4\/25\/23. https:\/\/www.acr.org\/-\/media\/acr\/files\/clinical-resources\/contrast_media.pdf"},{"key":"1930_CR18","doi-asserted-by":"publisher","unstructured":"Davis MB, Walsh MN. Cardio-obstetrics. Circ Cardiovasc Qual Outcomes. 2019;12(2):e005417. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.005417.","DOI":"10.1161\/CIRCOUTCOMES.118.005417."},{"key":"1930_CR19","unstructured":"Pryor K, Tarter L, Economy K, Weber B. Pericarditis management in pregnancy. Latest in cardiology, expert analysis accessed 3\/3\/23. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2022\/06\/06\/12\/17\/pericarditis-management-in-pregnancy"},{"key":"1930_CR20","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020;72(4):529\u2013556.\u00a0https:\/\/doi.org\/10.1002\/art.41191.\u00a0This systematic review provides evidence-based recommendations on the management of reproductive health in rheumatic and musculoskeletal diseases. In particular, the graded evidence on the use of certain medications during pregnancy and lactation is highly relevant to medications used in the treatment of pericarditis.","DOI":"10.1002\/art.41191."},{"issue":"7","key":"1930_CR21","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/rheumatology\/key053","volume":"57","author":"A Zbinden","year":"2018","unstructured":"Zbinden A, van den Brandt S, Ostensen M, Villiger PM, Forger F. Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology (Oxford). 2018;57(7):1235\u201342. https:\/\/doi.org\/10.1093\/rheumatology\/key053.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1930_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41584-022-00842-z","volume":"18","author":"C Sims","year":"2022","unstructured":"Sims C, Clowse MEB. A comprehensive guide for managing the reproductive health of patients with vasculitis. Nat Rev Rheumatol. 2022;18(12):711\u201323. https:\/\/doi.org\/10.1038\/s41584-022-00842-z.","journal-title":"Nat Rev Rheumatol"},{"key":"1930_CR23","doi-asserted-by":"publisher","unstructured":"Grant JK, Shah NP. The impact of physical activity on pericarditis. Curr Cardiol Rep. 2021;23(10):150. https:\/\/doi.org\/10.1007\/s11886-021-01578-0","DOI":"10.1007\/s11886-021-01578-0"},{"key":"1930_CR24","unstructured":"Shah N PDPARiPWAPhwaoF, 2017. Accessed 3\/02\/2023. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2017\/02\/09\/07\/24\/physical-activity-recommendations-in-patients-with-acute-pericarditis."},{"key":"1930_CR25","doi-asserted-by":"publisher","unstructured":"Tombetti E, Mule A, Tamanini S, et al. Novel Pharmacotherapies for recurrent pericarditis: current options in 2020. Curr Cardiol Rep. Jun 19 2020;22(8):59.\u00a0https:\/\/doi.org\/10.1007\/s11886-020-01308-y","DOI":"10.1007\/s11886-020-01308-y"},{"issue":"18","key":"1930_CR26","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","volume":"316","author":"A Brucato","year":"2016","unstructured":"Brucato A, Imazio M, Gattorno M, et al. Effect of Anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA. 2016;316(18):1906\u201312. https:\/\/doi.org\/10.1001\/jama.2016.15826.","journal-title":"JAMA"},{"key":"1930_CR27","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Klein AL, Imazio M, Cremer P, et al. Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis. N Engl J Med. 2021;384(1):31\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2027892. This phase 3, double-blinded, placebo-controlled, multicenter randomized withdrawal study among patients with symptomatic recurrent pericarditis demonstrated that rilonacept is highly effective in treating the active flare and led to a 96% reduction in risk of recurrent pericarditis. Results from this study led to US FDA approval of rilonacept in 2019.","DOI":"10.1056\/NEJMoa2027892"},{"key":"1930_CR28","doi-asserted-by":"crossref","unstructured":"Lotan D WY, Itelman E, Nir-Simchen M, Arad M, Kuperstein R. Management and outcome of acute and recurrent pericarditis during pregnancy. Eur Heart J. 2020;41(ehaa946.2157)(2).","DOI":"10.1093\/ehjci\/ehaa946.2157"},{"issue":"3","key":"1930_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5603\/KP.2019.0049","volume":"77","author":"V Regitz-Zagrosek","year":"2019","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Kardiol Pol. 2019;77(3):245\u2013326. https:\/\/doi.org\/10.5603\/KP.2019.0049.","journal-title":"Kardiol Pol"},{"issue":"5","key":"1930_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1345\/aph.1G428","volume":"40","author":"G Koren","year":"2006","unstructured":"Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40(5):824\u20139. https:\/\/doi.org\/10.1345\/aph.1G428.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"1930_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/BOR.0000000000000710","volume":"32","author":"M Birru Talabi","year":"2020","unstructured":"Birru Talabi M, Clowse MEB. Antirheumatic medications in pregnancy and breastfeeding. Curr Opin Rheumatol. 2020;32(3):238\u201346. https:\/\/doi.org\/10.1097\/BOR.0000000000000710.","journal-title":"Curr Opin Rheumatol"},{"key":"1930_CR32","doi-asserted-by":"publisher","unstructured":"Imazio M, Brucato A, Adler Y. A randomized trial of colchicine for acute pericarditis. N Engl J Med.\u00a02014;370(8):781.\u00a0https:\/\/doi.org\/10.1056\/NEJMc1315351.","DOI":"10.1056\/NEJMc1315351."},{"issue":"13","key":"1930_CR33","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","volume":"112","author":"M Imazio","year":"2005","unstructured":"Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.542738.","journal-title":"Circulation"},{"issue":"9","key":"1930_CR34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/art.24003","volume":"59","author":"YA de Man","year":"2008","unstructured":"de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241\u20138. https:\/\/doi.org\/10.1002\/art.24003.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1930_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izz313","volume":"26","author":"A Yu","year":"2020","unstructured":"Yu A, Friedman S, Ananthakrishnan AN. Incidence and predictors of flares in the postpartum year among women with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26(12):1926\u201332. https:\/\/doi.org\/10.1093\/ibd\/izz313.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"1930_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/rheumatology\/kex353","volume":"57","author":"PL Indraratna","year":"2018","unstructured":"Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(2):382\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/kex353.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1930_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/art.1780390721","volume":"39","author":"E Ben-Chetrit","year":"1996","unstructured":"Ben-Chetrit E, Scherrmann JM, Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum. 1996;39(7):1213\u20137. https:\/\/doi.org\/10.1002\/art.1780390721.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1930_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/eurheartj\/ehi197","volume":"26","author":"G Artom","year":"2005","unstructured":"Artom G, Koren-Morag N, Spodick DH, et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J. 2005;26(7):723\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehi197.","journal-title":"Eur Heart J"},{"issue":"8","key":"1930_CR39","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1093\/rheumatology\/keac177","volume":"61","author":"E Weber","year":"2022","unstructured":"Weber E, Millet A, Beghin D, et al. Safety of canakinumab during pregnancy: seven new cases. Rheumatology (Oxford). 2022;61(8):e229\u201331. https:\/\/doi.org\/10.1093\/rheumatology\/keac177.","journal-title":"Rheumatology (Oxford)"},{"key":"1930_CR40","doi-asserted-by":"publisher","unstructured":"\u2022 Brien ME, Gaudreault V, Hughes K, Hayes DJL, Heazell AEP, Girard S. A systematic review of the safety of blocking the IL-1 system in human pregnancy. J Clin Med.\u00a02021;11(1).\u00a0https:\/\/doi.org\/10.3390\/jcm11010225. In this systemic review, the use of IL-1 blockade in 88 pregnancies described in 22 case reports was assessed. The authors did not find any increase in adverse perinatal outcomes associated with the use of IL-1 blockade in pregnancy.","DOI":"10.3390\/jcm11010225"},{"issue":"12","key":"1930_CR41","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/rheumatology\/kex305","volume":"56","author":"T Youngstein","year":"2017","unstructured":"Youngstein T, Hoffmann P, Gul A, et al. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatology (Oxford). 2017;56(12):2102\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kex305.","journal-title":"Rheumatology (Oxford)"},{"key":"1930_CR42","doi-asserted-by":"publisher","unstructured":"Negro E, Costedoat-Chalumeau N, Nivuori M, Gabiati C, Pallini G, Brucato A. Anakinra during pregnancy in a difficult to treat case of recurrent pericarditis. Can J Cardiol. 2022.\u00a0https:\/\/doi.org\/10.1016\/j.cjca.2022.10.020.","DOI":"10.1016\/j.cjca.2022.10.020."},{"key":"1930_CR43","unstructured":"Drugs and Lactation Database (LactMed) [Internet] (https:\/\/www.ncbi.nlm.nih.gov\/). 2021. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501871\/. Accessed 03\/02\/2023."}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-023-01930-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-023-01930-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-023-01930-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T13:16:23Z","timestamp":1700054183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-023-01930-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1007\/s11886-023-01930-6","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"24 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MSG reports consultant fees from Abbvie and Horizon Therapeutics. BW reports scientific advisory board fees from Kinisika, Horizon Therapeutics (no longer active), and Novonordisk. MG reports scientific advisory board fees from Kinisika. MCH reports research grants paid to the institution from Genentech, U.S. NHLBI, and American Heart Association; consulting fees from CRISPR Therapeutics (no longer active); equity from Miga Health. AMV reports royalties from UpToDate (Editor and Peer Review); consulting fees from the Journal of the American College of Cardiology (Editorial Board); honoraria for visiting professor lecture from Rutgers University, Vanderbilt Medical Center, Westchester Medical Center, Columbia University, Cedars-Sinai Medical Center; and Advisory Board for Practice Update. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}